Your browser is no longer supported. Please, upgrade your browser.
Settings
VAR Varian Medical Systems, Inc. daily Stock Chart
VAR [NYSE]
Varian Medical Systems, Inc.
IndexS&P 500 P/E33.55 EPS (ttm)3.11 Insider Own0.20% Shs Outstand91.70M Perf Week3.46%
Market Cap9.57B Forward P/E23.52 EPS next Y4.44 Insider Trans-52.37% Shs Float91.51M Perf Month-1.68%
Income291.20M PEG3.35 EPS next Q1.19 Inst Own- Short Float8.01% Perf Quarter0.05%
Sales2.84B P/S3.37 EPS this Y2.40% Inst Trans0.13% Short Ratio10.00 Perf Half Y16.88%
Book/sh15.16 P/B6.89 EPS next Y13.07% ROA8.30% Target Price104.29 Perf Year22.32%
Cash/sh7.18 P/C14.54 EPS next 5Y10.00% ROE18.50% 52W Range75.94 - 107.87 Perf YTD31.31%
Dividend- P/FCF26.48 EPS past 5Y4.00% ROI16.50% 52W High-2.73% Beta0.64
Dividend %- Quick Ratio1.30 Sales past 5Y4.40% Gross Margin43.40% 52W Low38.17% ATR1.48
Employees7800 Current Ratio1.60 Sales Q/Q-16.10% Oper. Margin14.10% RSI (14)60.13 Volatility1.37% 1.61%
OptionableYes Debt/Eq0.26 EPS Q/Q-5.50% Profit Margin10.00% Rel Volume0.44 Prev Close104.40
ShortableYes LT Debt/Eq0.18 EarningsOct 25 AMC Payout0.00% Avg Volume733.25K Price104.93
Recom2.50 SMA202.68% SMA502.03% SMA20010.67% Volume145,846 Change0.51%
Sep-07-17Downgrade BTIG Research Buy → Neutral
May-16-17Initiated Goldman Neutral $92
May-08-17Upgrade Citigroup Neutral → Buy
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $82 → $90
Apr-27-17Downgrade Barrington Research Outperform → Mkt Perform
Jan-27-17Reiterated Barrington Research Outperform $102 → $98
Jan-23-17Reiterated RBC Capital Mkts Sector Perform $91 → $93
Jul-28-16Reiterated Barrington Research Outperform $93 → $102
Feb-17-16Reiterated RBC Capital Mkts Sector Perform $86 → $84
Jan-12-16Resumed Barrington Research Outperform $91
Dec-22-15Initiated RBC Capital Mkts Sector Perform $86
Nov-12-15Initiated Citigroup Neutral
Oct-20-15Downgrade Robert W. Baird Outperform → Neutral $101 → $82
Sep-28-15Downgrade Goldman Neutral → Sell
Jun-18-15Initiated Dougherty & Company Buy $105
Apr-30-15Downgrade JP Morgan Overweight → Neutral
Jan-29-15Reiterated Brean Capital Buy $87 → $96
Oct-23-14Reiterated ISI Group Neutral $86 → $82.50
Oct-23-14Reiterated Brean Capital Buy $95 → $85
Jun-30-14Initiated ISI Group Neutral $90
Oct-19-17 09:38AM  Varian Medical (VAR) Initiates Halcyon Treatment in Europe Zacks
Oct-17-17 08:15AM  UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System PR Newswire
Oct-11-17 12:34PM  Varian Medical Systems, Inc. Value Analysis (NYSE:VAR) : October 11, 2017 Capital Cube
Oct-10-17 08:26AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 10, 2017 Capital Cube
Oct-09-17 08:06AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Oct-02-17 08:15AM  Varian Publishes 2017 Sustainability Report PR Newswire
Sep-29-17 10:05AM  Varian Medical Initiates Treatment Using Halcyon System Zacks
Sep-28-17 08:30AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : September 28, 2017 Capital Cube
Sep-25-17 07:42AM  How Varian Medical Systems Is Advancing Cancer Care Market Realist
06:26AM  Varians Halcyon Reaches Milestone Achievements Market Realist
06:26AM  Why Most Analysts Recommend a Buy for Varian Medical Systems Market Realist
06:26AM  Key Growth Driver: Varian Medical Systems Launched Eclipse 15.5 Market Realist
Sep-21-17 08:45AM  Varian Announces Penn Medicine Treats World's First Patient on Halcyon System PR Newswire
Sep-20-17 08:15AM  Varian Ranks First in Overall Manufacturer, System, and Service Performance in 2017 Survey of Radiation Oncology Professionals PR Newswire
Sep-19-17 08:58AM  Varian Medical (VAR) Releases FDA-Approved Eclipse 15.5 Zacks
08:15AM  Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017 PR Newswire
Sep-18-17 08:15AM  Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5 PR Newswire
08:06AM  Varian Conducts Clinical Workshop, Strengthens Algeria Hold Zacks
Sep-14-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
08:00AM  Varian Holds First Clinical Workshop at New Algeria Facility PR Newswire
Sep-13-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Sep-12-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Aug-24-17 08:00AM  Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor Events PR Newswire
Aug-23-17 09:00AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : VAR-US : August 23, 2017 Capital Cube
Aug-21-17 05:24PM  ETFs with exposure to Varian Medical Systems, Inc. : August 21, 2017 Capital Cube
Aug-16-17 10:36AM  Varian Medical Systems Recent Stock Performance Market Realist
09:07AM  What Drove Varian to Revise Its Revenue Guidance Market Realist
08:22AM  Varian (VAR) Rides on Oncology and Proton Therapy Businesses Zacks
07:36AM  How Varian Is Harnessing Proton Therapy Market Opportunities Market Realist
Aug-15-17 10:36AM  Varians Halcyon Treatment System Sees Emerging Market Demand Market Realist
09:05AM  Varians Oncology Business Grows in Emerging Markets Market Realist
07:37AM  Why Varian Medical Systems Profitability Is Improving Market Realist
Aug-14-17 10:38AM  A Look at Varian Medical Systems Long-Term Goals Market Realist
09:07AM  Varian Medical Systems: Better Aligned, More Focused Market Realist
08:41AM  Varian Medical Systems to Hold Investor Meeting at ASTRO in San Diego PR Newswire
07:38AM  Analysts Recommendations for Varian Medical Systems Market Realist
Aug-12-17 12:41AM  Edited Transcript of VAR earnings conference call or presentation 26-Jul-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:06AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
07:10AM  Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators ACCESSWIRE
Aug-10-17 11:39AM  Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q3, 2017 By the Numbers : August 10, 2017 Capital Cube
09:55AM  Varian Medical (VAR) Signs Distribution Deal with Bionix Zacks
08:00AM  Varian Announces New VP of Investor Relations PR Newswire
Aug-09-17 08:15AM  Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation Therapy PR Newswire
Aug-08-17 08:15AM  First Patient Treated with Varian HyperArc High Definition Radiotherapy PR Newswire
Aug-07-17 07:20AM  Earnings Review and Free Research Report: Varian Medical Systems Reported Better than Expected Earnings ACCESSWIRE
Aug-04-17 07:49AM  Key Highlights from Varian Medical Systems 3Q17 Earnings Market Realist
Aug-01-17 08:00AM  Varian Selected to Provide Full Range of Software for New Proton Therapy Centers in UK and Denmark PR Newswire
Jul-28-17 09:43AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : July 28, 2017 Capital Cube
Jul-27-17 08:00AM  PetCure Oncology Selects Varian Halcyon Treatment System to Expand Access to Cancer Care for Pets PR Newswire
07:30AM  Varian Medical (VAR) Tops Earnings & Lags Revenues in Q3 Zacks
Jul-26-17 10:23PM  Varian tops 3Q profit forecasts Associated Press
04:25PM  Varian Installs Cyclotron at Georgia Proton Treatment Center PR Newswire
04:20PM  UZ Leuven Orders Varian Halcyon Cancer Treatment System PR Newswire
04:02PM  Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital PR Newswire
10:05AM  Investor Network: Varian Medical Systems, Inc. to Host Earnings Call Accesswire
Jul-25-17 09:32AM  Medical Instruments' Jul 26 Earnings Lineup: EW, TMO, VAR Zacks
08:15AM  Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017 PR Newswire
Jul-20-17 09:47AM  Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store? Zacks
Jul-18-17 08:15AM  Varian Eclipse Users Generate Highest Scoring Plans in International Treatment Plan Competition PR Newswire
Jul-11-17 08:00AM  Leading Cancer Center Commences Advanced Treatments Using Varian Edge Radiosurgery System PR Newswire
Jul-10-17 10:13AM  Thermo Fisher at a 52-Week High: What's Driving the Stock? Zacks
Jul-07-17 07:25AM  Phibro Animal Health & Zydus Cadila Plan to Expand in India Zacks
Jul-06-17 09:46AM  Here's Why You Should Add Abbott Laboratories Right Now Zacks
Jul-04-17 08:07AM  Varian Halcyon System Gets 510(k) Approval from the FDA Zacks
Jul-03-17 10:39AM  Varian Medical Systems: Analyzing Its Stock Performance Market Realist
09:11AM  Analysts Recommendations for Varian Medical Systems Market Realist
07:42AM  Varian Medical Systems Gets New Product Approval Market Realist
Jun-29-17 08:15AM  Varian Medical Systems Receives FDA 510(k) Clearance for Halcyon Treatment System PR Newswire
Jun-28-17 08:13AM  Varian Rides on Oncology and Proton Therapy Businesses Zacks
Jun-26-17 08:00AM  Varian Medical Systems Schedules Third Quarter FY2017 News Release and Conference Call PR Newswire
Jun-22-17 11:30AM  Major Milestone for UK's First High Energy Proton Therapy Center with Varian Cyclotron Installation PR Newswire
Jun-21-17 08:00AM  Varian Works with Sify Technologies to Host Data Remotely Across CTSI Network of Cancer Centers in India PR Newswire
Jun-20-17 08:15AM  Varian and National Centre for Particle Therapy in Denmark Attain Milestone with Successful Cyclotron Installation PR Newswire
Jun-19-17 04:16PM  ETFs with exposure to Varian Medical Systems, Inc. : June 19, 2017 Capital Cube
Jun-16-17 12:00PM  Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q2, 2017 By the Numbers : June 16, 2017 Capital Cube
07:47AM  Varian Showcases Halcyon System at DEGRO Meet, Stock Up Zacks
Jun-15-17 08:00AM  Varian Spotlights New Halcyon Radiotherapy Treatment System at DEGRO 2017 PR Newswire
Jun-05-17 08:15AM  Varian Joins Partnership to Develop Radiotherapy Centers in Vietnam PR Newswire
May-30-17 07:24PM  Seasonality And Sentiment Suggest Additional Upside For Varian Stock Forbes
08:56AM  Varian Medical at a 52-Week High: What's Driving the Stock? Zacks
07:45AM  Varian Medical (VAR) Up 9.8% Since Earnings Report: Can It Continue? Zacks
May-25-17 09:22AM  Varian (VAR) ProBeam Proton Therapy System Now in Thailand Zacks
08:15AM  Experts Present New Radiosurgery Techniques Using Varian Technology for Optimal Targeting of Multiple Metastases PR Newswire
May-24-17 01:43PM  Five charged with insider trading involving U.S. health agency Reuters
08:15AM  Varian Selected to Provide First Proton Therapy System in Thailand PR Newswire
May-11-17 09:22AM  Varian ProBeam Proton System Gets Okayed by Shonin in Japan Zacks
May-10-17 09:30AM  Zacks.com featured highlights: MOMO, HEICO, TAL Education Group, Chegg and Varian Medical Systems Zacks
08:00AM  Varian ProBeam Proton Therapy System Receives Shonin Approval PR Newswire
May-08-17 08:15AM  Varian Selected to Provide Compact Single-room Proton Therapy System for Treatment Center in Florida PR Newswire
02:30AM  New Varian Cancer Treatment Platform Draws Large Crowds at ESTRO 36 Tradeshow PR Newswire
May-06-17 04:30AM  Varian Launches Game-Changing Treatment Platform to Answer the Global Cancer Challenge PR Newswire
May-05-17 09:23AM  Just in case Heres what will happen to markets on Monday if Le Pen wins CNBC
May-04-17 04:01PM  Varex Imaging Announces Financial Results For The Second Quarter Of Fiscal Year 2017 PR Newswire
May-01-17 09:09AM  VARs Latest Analyst Recommendations after Its 2Q17 Results Market Realist
07:40AM  Key Highlights of Varian Medical Systems Fiscal 2Q17 Earnings Market Realist
Apr-28-17 09:51PM  Edited Transcript of VAR earnings conference call or presentation 26-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
Apr-27-17 08:45AM  Varian Medical (VAR) Beats on Earnings and Revenues in Q2 Zacks
08:00AM  Varian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and Proton Therapy at ESTRO 36 PR Newswire
Apr-26-17 04:30PM  Varian beats Street 2Q forecasts Associated Press
04:02PM  Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 PR Newswire
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation, verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Imaging Components segment offers X-ray imaging components for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer aided diagnostics, and industrial applications. It also provides Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes. This segment serves original equipment manufacturers, independent service companies, and end-users. In addition, the company offers products and systems for delivering proton therapy; and develops technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Option Exercise67.121,08873,02727,688Oct 13 03:23 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Sale101.551,088110,48926,600Oct 13 03:23 PM
WILSON DOW RPresident and CEOOct 06Option Exercise51.2315,059771,47381,835Oct 06 07:46 PM
ECKERT R ANDREWDirectorOct 06Option Exercise62.745,651354,54414,650Oct 06 07:55 PM
ECKERT R ANDREWDirectorOct 06Sale102.395,651578,5948,999Oct 06 07:55 PM
WILSON DOW RPresident and CEOOct 06Sale102.4015,0591,541,97866,776Oct 06 07:46 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Option Exercise0.00933027,533Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Sale107.29933100,10026,600Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Option Exercise0.001,088027,688Sep 13 11:25 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Sale107.331,088116,77826,600Sep 13 11:25 AM
WILSON DOW RPresident and CEOSep 07Option Exercise0.0015,059081,835Sep 08 03:05 PM
WILSON DOW RPresident and CEOSep 07Sale105.4115,0591,587,36766,776Sep 08 03:05 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Option Exercise81.9793176,31427,531Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Sale105.0093197,75526,600Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Option Exercise67.121,08873,02726,600Aug 15 07:56 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Sale97.911,088106,52526,600Aug 15 07:56 PM
WILSON DOW RPresident and CEOAug 07Option Exercise51.2315,059771,47381,835Aug 08 08:08 PM
WILSON DOW RPresident and CEOAug 07Sale96.4815,0591,452,89566,776Aug 08 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Option Exercise81.9793376,47827,533Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Option Exercise81.9773460,16627,361Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Sale104.3873476,61427,261Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Sale105.0093397,96526,600Jul 13 07:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Option Exercise67.121,08873,02727,688Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Option Exercise67.1286357,92528,224Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Sale104.4886390,16627,361Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Sale104.491,088113,69026,600Jul 13 07:59 PM
WILSON DOW RPresident and CEOJul 10Option Exercise51.2315,060771,52481,836Jul 11 07:26 PM
WILSON DOW RPresident and CEOJul 10Sale103.3715,0601,556,70166,776Jul 11 07:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Option Exercise81.9726,0922,138,76152,692Jun 21 04:49 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Sale105.0026,0922,739,66026,600Jun 21 04:49 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Option Exercise81.9773460,16628,095Jun 14 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Sale101.9173474,80027,361Jun 14 07:07 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Option Exercise67.121,08772,95927,687Jun 13 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Option Exercise67.1286357,92528,224Jun 13 07:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Sale101.2586387,37827,361Jun 13 07:11 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Sale101.201,087110,00026,600Jun 13 07:07 PM
GUERTIN TIMOTHY EDirectorJun 09Sale103.2216,0001,651,54675,800Jun 12 07:48 PM
LARET MARK RDirectorJun 08Sale103.471,428147,7612,161Jun 09 04:02 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Option Exercise70.6356,5733,995,84883,173Jun 02 06:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Sale99.7656,5735,643,90026,600Jun 02 06:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Option Exercise81.9719,8191,624,56347,180Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Sale99.6719,8191,975,36027,361Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Option Exercise67.1286257,85728,223May 12 06:48 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Sale96.3986283,08427,361May 12 06:48 PM
BOSTROM SUSAN LDirectorMay 02Sale91.083,589326,9023,809May 03 06:29 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 12Option Exercise67.1286457,99227,914Apr 13 07:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 12Sale89.7486477,53327,050Apr 13 07:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 17Option Exercise74.063,876287,05730,926Mar 20 07:38 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 17Sale91.753,876355,62327,050Mar 20 07:38 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 13Option Exercise67.1286257,85727,912Mar 14 08:34 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 13Sale87.8986275,75827,050Mar 14 08:34 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 01Option Exercise67.1210,353694,89337,403Mar 02 08:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 01Sale84.8110,353878,03827,050Mar 02 08:04 PM
LARET MARK RDirectorFeb 22Option Exercise60.0111,302678,17714,891Feb 24 05:10 PM
LARET MARK RDirectorFeb 22Sale83.5611,302944,4083,589Feb 24 05:10 PM
DUGAN REGINA EDirectorFeb 21Option Exercise0.002,16102,161Feb 22 05:20 PM
ILLINGWORTH DAVID JDirectorFeb 21Option Exercise0.002,16105,134Feb 22 05:17 PM
LARET MARK RDirectorFeb 21Option Exercise0.002,16103,589Feb 22 05:15 PM
GUERTIN TIMOTHY EDirectorFeb 21Option Exercise0.002,16102,161Feb 22 05:12 PM
ECKERT R ANDREWDirectorFeb 21Option Exercise0.002,16109,304Feb 22 05:08 PM
BOSTROM SUSAN LDirectorFeb 21Option Exercise0.002,16107,398Feb 22 05:02 PM
WILSON DOW RPresident and CEOJan 05Option Exercise52.8313,334704,43577,625Jan 06 05:14 PM
WILSON DOW RPresident and CEOJan 05Sale88.7413,3341,183,26064,291Jan 06 05:14 PM
KUO JOHN WSVP, Gen Counsel and SecretaryDec 08Sale90.331,267114,45124,027Dec 08 08:32 PM
WILSON DOW RPresident and CEODec 05Option Exercise52.8310,000528,30074,291Dec 05 09:18 PM
WILSON DOW RPresident and CEODec 05Sale90.0310,000900,31164,291Dec 05 09:18 PM
VERHOEF CLARENCE RSVP, Finance, Corp ControllerNov 21Option Exercise0.001,34706,050Nov 22 06:48 PM
WILSON DOW RPresident and CEONov 07Option Exercise52.8310,000528,30070,598Nov 08 06:38 PM
WILSON DOW RPresident and CEONov 07Sale90.5910,000905,90760,598Nov 08 06:38 PM
GUERTIN TIMOTHY EDirectorOct 31Sale90.324,000361,29691,800Nov 01 09:55 PM
KUO JOHN WSVP, Gen Counsel and SecretaryOct 20Option Exercise83.7021,2661,779,96445,293Oct 20 09:14 PM
KUO JOHN WSVP, Gen Counsel and SecretaryOct 20Sale103.7021,2662,205,28424,027Oct 20 09:14 PM